Publication | Closed Access

Structural optimization, synthesis and in vitro synergistic anticancer activities of combinations of new N3-substituted dihydropyrimidine calcium channel blockers with cisplatin and etoposide

Medicinal ChemistryPolymer-drug ConjugateMedicineAnti-cancer AgentStructural OptimizationPharmacologyRadiation OncologyDrug Discovery